| Citation: | XU Yan, WU Linke, ZHANG Qiwan, ZHANG Kai, HUANG Baoli. Application of HACCP system in the whole process management of arm infusion port for patients with lung cancer chemotherapy[J]. Chinese Journal of General Practice, 2026, 24(4): 703-706. doi: 10.16766/j.cnki.issn.1674-4152.004472 |
| [1] |
唐君媛, 张桂新, 陈琳, 等. 塞来昔布联合化疗对晚期非小细胞肺癌合并慢性阻塞性肺疾病患者的抗炎作用及其机制研究[J]. 中国现代医学杂志, 2023, 33(17): 23-29.
TANG J Y, ZHANG G X, CHEN L, et al. Anti-inflammatory effect and mechanism of celecoxib combined with chemotherapy in patients with advanced non-small cell lung cancer complicated with chronic obstructive pulmonary disease[J]. China Journal of Modern Medicine, 2023, 33(17): 23-29.
|
| [2] |
王学焕, 马春华, 刘梅. 磺胺嘧啶银乳膏治疗1例静脉输液港港座外露患者的护理体会[J]. 中华全科医学, 2024, 22(7): 1264-1266. doi: 10.16766/j.cnki.issn.1674-4152.003613
WANG X H, MA C H, LIU M. Nursing experience of silver sulfadiazine cream in the treatment of a patient with exposure of intravenous infusion port[J]. Chinese Journal of General Practice, 2024, 22(7): 1264-1266. doi: 10.16766/j.cnki.issn.1674-4152.003613
|
| [3] |
曾翠芳, 吴文娟, 张星霞, 等. IMPACT管理模式用于乳腺癌植入式静脉输液港化疗患者自我护理及管理能力效果观察[J]. 华西医学, 2023, 38(6): 878-883.
ZENG C F, WU W J, ZHANG X X, et al. Effect of IMPACT management mode on self-care and management abilities of patients with breast cancer undergoing chemotherapy with implantable venous access port[J]. West China Medical Journal, 2023, 38(6): 878-883.
|
| [4] |
李佳利, 陈宇, 钱建平, 等. 融合HACCP体系的农产品区块链追溯系统精准上链机制改进[J]. 农业工程学报, 2022, 38(20): 276-285.
LI J L, CHEN Y, QIAN J P, et al. Improvement of the precise up-chain mechanism of the agricultural products blockchain traceability system integrating the HACCP system[J]. Transactions of the Chinese Society of Agricultural Engineering, 2022, 38(20): 276-285.
|
| [5] |
孙少华, 张国宗, 张心怡. 基于危害分析与关键控制点和流程再造理论的大型医院静脉采血流程优化与对策研究[J]. 中国医药导报, 2024, 21(12): 173-177.
SUN S H, ZHANG G Z, ZHANG X Y. Optimization and countermeasures of venous blood collection process in large hospitals based on hazard analysis and critical control point and process reengineering theory[J]. China Medical Herald, 2024, 21(12): 173-177.
|
| [6] |
周爱文, 王鑫, 孙梦露, 等. 危害分析和关键控制点法在产前诊断技术服务医疗风险管理中的研究与应用[J]. 中国医药导报, 2024, 21(11): 176-180.
ZHOU A W, WANG X, SUN M L, et al. Research and application of hazard analysis critical control point method in medical risk management of prenatal diagnostic technology services[J]. China Medical Herald, 2024, 21(11): 176-180.
|
| [7] |
金光鑫, 张芳琴, 王雅雯, 等. 超声联合DSA引导下经上臂静脉输液港植入术在恶性肿瘤化疗患者中的临床应用研究[J]. 介入放射学杂志, 2024, 33(7): 733-737.
JIN G X, ZHANG F Q, WANG Y W, et al. Clinical application of ultrasound combined with DSA-guided implantation of totally implantable venous access port via upper arm vein approach in chemotherapy for patients with malignant tumors[J]. Journal of Interventional Radiology, 2024, 33(7): 733-737.
|
| [8] |
杨贵丽, 郑海燕, 毛燕, 等. 肺癌化疗病人输液港相关血栓形成的影响因素分析及护理对策[J]. 蚌埠医学院学报, 2022, 47(9): 1272-1275.
YANG G L, ZHENG H Y, MAO Y, et al. Analysis of influencing factors and nursing strategies of infusion port-related thrombosis in chemotherapy patients with lung cancer[J]. Journal of Bengbu Medical University, 2022, 47(9): 1272-1275.
|
| [9] |
史秋敏, 徐玮, 马逊, 等. 基于危害分析与关键控制点理论的精准护理在糖尿病肾衰竭血液透析中的应用效果[J]. 川北医学院学报, 2023, 38(11): 1574-1578.
SHI Q M, XU W, MA X, et al. Application effect of precision nursing based on hazard analysis and critical control point theory in hemodialysis with diabetes and renal failure[J]. Journal of North Sichuan Medical College, 2023, 38(11): 1574-1578.
|
| [10] |
吴伟勤, 陈利芬, 周雪梅, 等. 化疗结束后延长输液港维护时间对导管功能及相关并发症的影响[J]. 中国实用护理杂志, 2022, 38(12): 930-935.
WU W Q, CHEN L F, ZHOU X M, YU R, YANG Y H, et al. Effect of prolonging the maintenance time of port on ports'function and catheter related complications after cancer patients completing chemotherapy[J]. Chinese Journal of Practical Nursing, 2022, 38(12): 930-935.
|
| [11] |
柴苏婉, 陈丹, 朱金星, 等. 预见性干预联合风险管理对静脉输液港化疗肺癌患者感染及堵塞的影响[J]. 河北医药, 2024, 46(6): 946-949.
CHAI S W, CHEN D, ZHU J X, CHEN X S, et al. Influence of predictive intervention combined with risk management on the infection and blockage of lung cancer patients undergoing intravenous chemotherapy using a chemo port[J]. Hebei Medical Journal, 2024, 46(6): 946-949.
|
| [12] |
周振宇, 顾喜喜, 鲍旭霞, 等. 肿瘤化疗患者并发输液港导管相关血栓的危险因素及治疗策略[J]. 复旦学报: 医学版, 2022, 49(6): 898-904, 954.
ZHOU Z Y, GU X X, BAO X X, XIA H S, FAN Y, YU F, SHI Z Y, et al. Analysis of risk factors and treatment strategies of implantable venous access port catheter-related thrombosis in chemotherapeutic patients[J]. Fudan University Journal of Medical Sciences, 2022, 49(6): 898-904, 954.
|
| [13] |
黄晓钰, 吴丽红. 肿瘤患者输液港相关性血流感染危险因素的研究进展[J]. 四川医学, 2022, 43(7): 717-721.
HUANG X Y, WU L H. Research progress on risk factors of port-related bloodstream infections in cancer patients[J]. Sichuan Medical Journal, 2022, 43(7): 717-721.
|
| [14] |
LAFACE C, LAFORGIA M, MOLINARI P, et al. Intra-Arterial infusion chemotherapy in advanced pancreatic cancer: a comprehensive review[J]. Cancers (Basel), 2022, 14(2): 450-453. doi: 10.3390/cancers14020450
|
| [15] |
SUN Y, WU X. Complications of implanted port catheters and peripherally inserted central catheters in chemotherapy-treated cancer patients: a meta-analysis[J]. Adv Clin Exp Med, 2023, 32(5): 523-532.
|